NCT01064622 2024-11-19Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic CancerNational Cancer Institute (NCI)Phase 2 Completed118 enrolled 14 charts